"GAMMED" IZABELA CHUCHROWSKA
- Address
- ul. Lelechowska 5, 02-351 Warsaw, Poland
GAMMED IZABELA CHUCHROWSKA - Neuroendocrine Tumor Research
GAMMED IZABELA CHUCHROWSKA is a specialized clinical research center focusing on advanced therapeutic approaches for neuroendocrine tumors. The center participates in cutting-edge research evaluating novel treatment modalities for patients with complex oncological conditions, particularly those affecting the gastroenteropancreatic system.
- Peptide receptor radionuclide therapy (PRRT) with 177Lu-edotreotide for gastroenteropancreatic neuroendocrine tumors
- Comparative efficacy studies of targeted therapies versus standard treatments in progressive, inoperable GEP-NET
- Advanced oncology trials focusing on somatostatin receptor-positive tumors
The center's research portfolio emphasizes precision medicine approaches for patients with rare and challenging malignancies. Through participation in international multicenter trials, GAMMED contributes to the development of innovative treatment strategies designed to improve progression-free survival and clinical outcomes for patients with neuroendocrine neoplasms of gastroenteric and pancreatic origin.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Novartis Pharma AG1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in "GAMMED" IZABELA CHUCHROWSKA
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of [177Lu]Lu-DOTA-TATE and Octreotide LAR in Grade 1 and 2 Advanced Gastroenteropancreatic Neuroendocrine Tumors | Novartis Pharma AG | Phase III | Recruiting | Sep 2025 | — |
IMP list
lock Showing 1 of 12 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Arginine Hydrochloride | 1 | Unknown | 2025-09-08 | 2025-09-08 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.